MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Dopamine transporter in the brain is linked to irritable bowel syndrome in Parkinson´s disease

    K. Murtomäki, J. Joutsa, T. Mertsalmi, E. Jaakkola, E. Mäkinen, R. Levo, M. Eklund, S. Nuuttila, E. Pekkonen, T. Noponen, T. Ihalainen, V. Kaasinen, F. Scheperjans (Helsinki, Finland)

    Objective: To assess correlations between gastrointestinal symptoms and dopamine transporter (DAT) changes in striatal and extrastriatal areas in Parkinson´s disease (PD) patients. Background: Gastrointestinal symptoms…
  • 2023 International Congress

    Analysis of the network of genes related to Parkinson’s and identification of key proteins

    H. Ghapani, D. Morshedi, S. Parsafar, F. Aliakbari (Tehran, Islamic Republic of Iran)

    Objective: Parkinson's disease (PD) is one of the increasing age-related diseases with no definite treatment. PD is considered as a disorder with genetic and non-genetic…
  • 2023 International Congress

    Anodal transcranial direct current stimulation could change the metabolomic profiles of cerebrospinal fluid in Parkinson’s disease

    W. Jang, H-T. Kim (Gangneung, Republic of Korea)

    Objective: We tried to identify meaningful metabolite change after anodal tDCS in clinically diagnosed PD patients by adopting metabolomic analysis Background: Transcranial direct current stimulation…
  • 2023 International Congress

    Deep brain stimulation for movement disorders: Assessing disparities in access to care

    Z. Rifi, M. Harary, L. Remore, K. Fu, A. Bari (Los Angeles, USA)

    Objective: To investigate the impact of non-disease related factors (sex, race, age, language, or socioeconomic status) on the likelihood of movement disorders patients receiving Deep…
  • 2023 International Congress

    Variant frequencies in dystonia and Parkinson’s disease genes cross phenotypic boundaries

    L. Lange, A. Illarionova, K. Grütz, EJ. Vollstedt, B-H. Laabs, S. Löns, G. Kilic-Berkmen, F. Hinrichs, H. Padlock, L. Screven, T. Bäumer, H. Jinnah, N. Brüggemann, Z-H. Fang, K. Lohmann, C. Klein (Luebeck, Germany)

    Objective: To investigate the frequency of genetic variants in dystonia (DYT) genes in patients with PD and vice versa. Background: The impact of genetic variants…
  • 2023 International Congress

    Consanguinity is the key player in complexity of Mendelian form of neurodegeneration with brain iron accumulation in Pakistan

    SHB. Rehman (Bannu, Pakistan)

    Objective: In the current work, we recognized big inbreed Pakistani family with autosomal recessive NBIA containing several affected individuals. Aim of the research work was…
  • 2023 International Congress

    Olfactory sniffing is altered in patients with Parkinson’s disease

    M. Andelman-Gur, N. Hezi, A. Ezra, J. Zitser, T. Gurevich, N. Sobel (Rehovot, Israel)

    Objective: To develop an objective non-verbal non-task-dependent olfactory test for PD detection. Background: Olfactory decline may precede motor symptoms by several years or decades in…
  • 2023 International Congress

    Can a single-session of weight-shift training support people with Parkinson’s step from a freeze?

    Y. Russo, P. Leveridge, J. Ye, Z. Wang, M. Wilson, A. Nieuwboer, S. Lamb, E. Kal, M. Norris, W. Young (Exeter, United Kingdom)

    Objective: To assess the efficacy and the safety of a weight-shift (WS) intervention used in a complex and demanding gait context Background: Freezing of gait…
  • 2023 International Congress

    Changes in artistic style and Parkinson’s Disease

    AM. Diezma Martín, G. Tabar Comellas, MI. Morales-Casado, DD. Garcia Melendez, JW. Ruiz Gómez, P. Quintana Castro, M. Ennazeh Elkhaili, D. Rivero Rodríguez, N. López Ariztegui (Toledo, Spain)

    Objective: We present a Parkinson’s disease (PD) patient in whom dopamine agonists produced a dramatic change in her art style and production, and the subsequent…
  • 2023 International Congress

    Demographic, clinical and genetic factors affecting amantadine response among patients with Parkinson disease

    J. Yu, L. Saadatpour, H. Kaur, I. Mata, H. Fernandez (Cleveland, USA)

    Objective: To identify factors that correlate with efficacy and tolerability of amantadine to predict therapeutic outcomes Background: Amantadine is the only commercially available medication to…
  • « Previous Page
  • 1
  • …
  • 140
  • 141
  • 142
  • 143
  • 144
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • An atypical and interesting feature of Parkinson´s disease
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley